HPV Genotyping Real-time PCR Kit
Product Introduction
Human Papilloma Virus (HPV) is becoming a menace worldwide, especially to the developing world, due to its involve-
ment in a variety of malignancies, with cervical cancer being the most important and prevalent. There are many HPV
types: HPV 16/18 are the most carcinogenic but few others are also characterized as high-risk (HR). This kit is a qualita-
tive in vitro test for the detection of Human Papillomavirus (HPV) nucleic acid in cervical specimens collected by a
health care provider. The device identifies HPV genotypes 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66 and
68, while reporting the concurrent detection of the HPV genotypes 26, 73 and 82 at clinically relevant infection levels.
15 high-risk HPV types:
16 18 31 33 35 39 45 51 52 53 56 58 59 66 68
HPV HPV HPV HPV HPV HPV HPV HPV HPV HPV HPV HPV HPV HPV HPV
3 medium-risk HPV types: 2 low-risk HPV types:
26 73 82 6 11
HPV HPV HPV HPV HPV
Product Features
• Simple Operation: From sample processing to detection, results can be completed within 90 minutes.
• Ease of Use: Features a straightforward protocol with minimal hands-on steps, reducing the risk of procedural errors and
improving operational efficiency.
• Strong Specificity: No cross reaction with a variety of other types of HPV and similar pathogens.
• Internal Control Included: Human genome β-Globin gene acted as a non-competitive internal control (IC) to monitor the
entire extraction and detection process, ensuring reliability and quality of the results.
Product Specifications
Sample Type Cervical specimens
Limit of Detection (LoD) 1000 copies/mL
Target Genes L1 region
Internal Control Human genome β-Globin gene
Precision CV 5%
Compatible Platform LineGene 9600 Plus (FQD-96A) , QuantGene 9600 FQD-96C
Validated Collection Kits BSC93 Universal Transport Medium
Validated Extraction Kits BSC57 MagaBio plus Virus DNA/RNA Purification Kit
Detection Time ≈60 min
Storage Condition -25℃ ~ -15℃ away from light
Product Workflow
1 Label the tube with patient
identification information 2 Sampling
3 Primary Tube
4 Transfer to Deep
Well Plate
5 Nucleic Acid
Purification system
6 System setup
7 qPCR analysis
8 Report
Clinical Performance
The positive percent agreement, negative percent agreement and overall percent agreemment were 99.84%
(99.12%-99.995%), 99.64% (97.99%-99.99%), 99.78% (99.21%-99.97%) respectively.
Ordering Information
Product Name Cat. No. Package Storage Condition
BSJ01M1 48 tests/kit
HPV Genotyping Real-time PCR Kit -25℃ ~ -15℃
BSJ01L1 96 tests/kit away from light
For in vitro diagnostic use only.
For professional use only.
Add 1192 BinAn Rd, Binjiang District 310053 Hangzhou, PEOPLE'S REPUBLIC OF CHINA Web: www.bioer.com
Tel +86-571-87774513 Fax +86-571-87774553 E-Mail [email protected] E-Date 2024.09
BIO J01-2409